Dear Valued Visitor,

We have noticed that you are using an ad blocker software.

Although advertisements on the web pages may degrade your experience, our business certainly depends on them and we can only keep providing you high-quality research based articles as long as we can display ads on our pages.

To view this article, you can disable your ad blocker and refresh this page or simply login.

We only allow registered users to use ad blockers. You can sign up for free by clicking here or you can login if you are already a member.

E Mark Saad


  • Director at Axsome Therapeutics Inc. (AXSM), 2019-06-10
  • Director at Ra Medical Systems Inc. (RMED), 2019-06-07
  • Chief Financial Officer at Cytori Therapeutics Inc. (CYTX), 2014-04-15
Insider Trading: Purchases See All
Company Symbol Price Amount Relationship Remaining Holdings Date Form 4
AXSM $22.33 3,500 Director 7,002 2019-05-23 Filing
CYTX $2.54 600 Officer 152,500 2012-03-14 Filing
CYTX $2.55 9,400 Officer 151,900 2012-03-14 Filing
CYTX $3.14 2,700 Officer 122,500 2011-08-12 Filing
CYTX $3.13 800 Officer 119,800 2011-08-12 Filing